James M Crawford, MD, PhD. jcrawford1@northwell.edu. Executive Director and Senior Vice President for Laboratory Services, . Northwell Health. Professor and Chair, Pathology/Lab Medicine. Hofstra Northwell School of Medicine. ID: 647891
DownloadNote - The PPT/PDF document "Moving to Clinical Lab 2.0" is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
Moving to Clinical Lab 2.0James M Crawford, MD, PhDjcrawford1@northwell.eduExecutive Director and Senior Vice President for Laboratory Services, Northwell HealthProfessor and Chair, Pathology/Lab MedicineHofstra Northwell School of MedicineManhasset, NY
1
Deliver more Value!
Get Paid More Dollars!
Slide2Disclosures2ClaraPath (start up from Cold Spring Harbor Laboratories)*2015: Technical Advisory CommitteeNorthwell Health Genomics Alliance (with OPKO Health)2015: President of LLC*Technology Transfer
Slide3What is “Clinical Lab 2.0”3Transactional Lab Data → Integrative InformationReactive: Order/Result → Proactive: Need/InformationLab = Commodity → Lab = Essential system assetTechnical experts only → SME on Health Care deliveryWe don’t look at our own data → We are the experts on what our data mean Identification of Risk Escalation of Health Care Gaps-in-Care Outcomes (or not)
Predicative Analytics
We can help drive financial health of system
Slide4Who are our Stakeholders?4Those who pay for our information: Payers Health system Employers Those who make health care decisions: Providers Consumers“Value” is what someone is willing to pay for.Listen to their needs.
Are we meeting their needs?
Prove it.
Slide5“Clinical Lab 2.0” is Leadership, not Followship5
Slide6What are we responding to?6DownsideUnder-appreciation by our StakeholdersUnder-utilization of our expertiseRisk of not controlling our destinyUpsideExtraordinary opportunity to provide better health careUnrealized opportunity to support better financial outcomes for our Stakeholders*ABN, Advanced Beneficiary Notice
Slide7Objectives of this Workshop7To identify measures of Success for a “2.0” clinical laboratoryTo understand the strategies for getting thereTo learn tactical approaches from review of examplesTo share in lessons learned
Slide88“HERE”“THERE”
Slide99“HERE”“THERE”Be IntrusiveBe InsistentBe Creative
Learn new SkillsBuild new Teams
Take Risks!
Slide10“Innovation” in detail10Inpatient: AKI, antibiotic stewardship, sepsis bundles….Outpatient: CKD, diabetes, anti-coagulation….“Innovation” at global level
Disease Management teams
Precision Medicine
Where is the Opportunity?
10
Financial Performance
Not your “3%” – the
other
97%
Impact of Lab on the Total Health Care Spend
Impact of Lab on the Total Revenue Cycle
Slide1111LabStake-holderOutcome
Clinical Lab 1.0
Slide1212LabStake-holder
Outcome
Clinical Lab 2.0
Slide13The Structure of Today’s Workshop13Khosrow Shotorbani: Why is Clinical Lab 2.0 different?Tarush Kothari, MD, MPH: Success story with AKIIlan Rubinfeld, MD: Health System CMO perspectiveMonique Dodd, DPharm/ Building the Value Statements Kathleen Swanson, MS, RPhAron
Seidman Changing IT infrastructure
Informatics PanelOpen Q&A Session
Slide1414jcrawford1@northwell.edu
Slide15Today's Top Docs
Related Slides
World War 3 will start in 2020. ???
Risk Management For a Small Business
Gate Drivers Presenter: Bipolar Business
Understanding a New Era of Strategic Com
Moving Checklist: Moving DayOn
“ Moving 101”
Trends In International Moving
Moving Business Chicago
Moving Business Chicago
MOVING 101:A simple guide to a
Moving Average, MAD, Tracking 
1 Moving to MARC 21 -
TEXT As MOVING IMAGE Week 05